The University of Pittsburgh was awarded $8 million to continue researching a new therapy for Parkinson's patients.

Nilotinib, a blood cancer medicine, was previously shown to improve movement and mental function in a small group of patients ...

Generic net revenue increased by 9% to $427.35 million, driven by the strong performance of new product launches and ...

(WDRB) -- Norton Healthcare's Neuroscience Institute will soon begin offering a non-invasive procedure to reduce tremors in Parkinson's patients ... but now there's a new method with no incisions ...

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

With over 30 years of specialized research in neuroscience and drug development and having served as the Executive Director of the Critical Path for Parkinson's Consortium ... I am looking forward to ...

Critical Path Institute today announced key leadership appointments: Diane Stephenson, Ph.D., has been promoted to Vice President of Neurology, and Nadine Tatton, Ph.D., has been welcomed as the new ...

The selling price is an indication that the FDA’s planned sunsetting of the rare pediatric disease voucher program may be ...

Two recent chemistry studies pinpoint reactions that may link the gut microbiome to the development of Parkinson's disease.

A drug used to treat glaucoma may protect against tau protein buildup in the brain, a key marker of dementias such as ...

“The evidence would suggest that perhaps we need to investigate this pathway and perhaps this drug in both Parkinson’s, ...

Favorable capital market conditions last week enabled the company to raise over $15 million from secondary offerings, and the proceeds allow the Company to fund fully the costs of this upcoming ...